DePuydt L E, Schuit K E, Smith S D
Children's Hospital of Pittsburgh, PA.
Crit Care Med. 1993 Sep;21(9):1324-7. doi: 10.1097/00003246-199309000-00015.
To study the effect of long-term extracorporeal membrane oxygenation (ECMO) support on neutrophil function.
A prospective, clinical investigation.
A pediatric intensive care unit.
Four groups of patients: ECMO group 1, newborns after 1 day of ECMO support (n = 10); ECMO group 2, newborns after 5 days of ECMO support (n = 6); group 3, normal newborns (n = 20); group 4, normal adults (n = 30).
Two mL of heparinized blood was obtained from patients in each group. A modification of the Smith and Rommel technique was used to measure neutrophil phagocytosis and killing utilizing live Candida tropicalis as the test organism. Neutrophils were incubated for 90 mins in normal adult serum with live Candida. Viability of Candida after phagocytosis was tested by vital fluorochrome staining. Phagocytic index (the number of neutrophils with intracytoplasmic Candida divided by the total neutrophils) and candidicidal ratio (neutrophils with dead Candida divided by total neutrophils with Candida) were determined daily.
Neutrophils from ECMO group 1 (day 1) and ECMO group 2 (day 5) patients had significantly higher phagocytosis indices (72.8 +/- 20 and 76 +/- 18) and candidicidal ratios (0.15 +/- 0.1 and 0.16 +/- 0.09) compared with neutrophils from group 3 patients (normal neonates) (64 +/- 7 and 0.06 +/- 0.04). The phagocytosis indices were significantly lower in neutrophils from ECMO group 1 (day 1) and ECMO group 2 (day 5) patients compared with group 4 (adults) patients (86 +/- 9). However, the candidicidal ratios in neutrophils from ECMO groups 1 and 2 (ECMO day 1 and day 5) patients were equal to that value in group 4 (adults) (0.10 +/- 0.04). ECMO support for 5 days (ECMO group 2 vs. group 1) did not significantly change either the phagocytosis index or candidicidal ratio.
Phagocytosis and intracellular killing by neutrophils of ECMO-supported neonates were significantly greater than those values found in normal newborns. ECMO support for 5 days produced no significant changes in neutrophil phagocytosis or killing.
研究长期体外膜肺氧合(ECMO)支持对中性粒细胞功能的影响。
一项前瞻性临床研究。
儿科重症监护病房。
四组患者:ECMO组1,接受ECMO支持1天后的新生儿(n = 10);ECMO组2,接受ECMO支持5天后的新生儿(n = 6);第3组,正常新生儿(n = 20);第4组,正常成年人(n = 30)。
从每组患者中采集2 mL肝素化血液。采用Smith和Rommel技术的改良方法,以热带假丝酵母菌作为测试微生物来测量中性粒细胞的吞噬作用和杀伤能力。将中性粒细胞与活的假丝酵母菌在正常成人血清中孵育90分钟。吞噬作用后假丝酵母菌的活力通过活性荧光染料染色进行检测。每天测定吞噬指数(胞质内有假丝酵母菌的中性粒细胞数量除以中性粒细胞总数)和杀念珠菌率(有死亡假丝酵母菌的中性粒细胞数量除以有假丝酵母菌的中性粒细胞总数)。
与第3组患者(正常新生儿)的中性粒细胞(吞噬指数64±7,杀念珠菌率0.06±0.04)相比,ECMO组1(第1天)和ECMO组2(第5天)患者的中性粒细胞吞噬指数(分别为72.8±20和76±18)和杀念珠菌率(分别为0.15±0.1和0.16±0.09)显著更高。与第4组患者(成年人)的中性粒细胞(吞噬指数86±9)相比,ECMO组1(第1天)和ECMO组2(第5天)患者的中性粒细胞吞噬指数显著更低。然而,ECMO组1和2(ECMO第1天和第5天)患者的中性粒细胞杀念珠菌率与第4组患者(成年人)的杀念珠菌率(0.10±0.04)相当。ECMO支持5天(ECMO组2与组1相比),吞噬指数或杀念珠菌率均无显著变化。
接受ECMO支持的新生儿中性粒细胞的吞噬作用和细胞内杀伤能力显著高于正常新生儿。ECMO支持5天,中性粒细胞的吞噬作用或杀伤能力无显著变化。